glp 1 drug novo nordisk cuts GLP-1 prices for cash buyers Novo Nordisk cuts GLP-1 prices

National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)

Several new weight loss treatments are in development, including Amgen's MariTide

Teva Pharmaceuticals has launched the first generic GLP-1 drug for weight loss in adults and adolescents

Eli Lilly, makers of weight loss injection Zepbound, could soon be making its GLP-1 drug in pill form.

Prebiotic supports digestive health and regularity extends GLP-1 lifespan for prolonged effects on glucose regulation and hunger suppression.*

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been studied for their cardiovascular benefits in type 2 diabetes